Inventor
MOHAN VENKATRAMAN
US18 patents
⚠️ This page may combine multiple inventors who share the name “MOHAN VENKATRAMAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
15 patentsUS6534639B1Mar 18, 2003
Guanidinium functionalized oligonucleotides and method/synthesis
ISIS PHARMACEUTICALS INC261 citations99
US5554746ASep 10, 1996
Lactam nucleic acids
ISIS PHARMACEUTICALS INC160 citations99
US6369209B1Apr 9, 2002
Oligonucleotides having A-DNA form and B-DNA form conformational geometry
ISIS PHARMACEUTICALS INC66 citations96
US6271358B1Aug 7, 2001
RNA targeted 2′-modified oligonucleotides that are conformationally preorganized
ISIS PHARMACEUTICALS INC192 citations96
US7119184B2Oct 10, 2006
Oligonucleotides having A-DNA form and B-DNA form conformational geometry
ISIS PHARMACEUTICALS INC28 citations92
US6969763B1Nov 29, 2005
Molecular interaction sites of interleukin-2 RNA and methods of modulating the same
ISIS PHARMACEUTICALS INC41 citations92
US6967242B2Nov 22, 2005
Antimicrobial 2-deoxystreptamine compounds
ISIS PHARMACEUTICALS INC35 citations92
US6759523B2Jul 6, 2004
Antimicrobial 2-deoxystreptamine compounds
ISIS PHARMACEUTICALS INC30 citations92
US6737520B2May 18, 2004
Oligonucleotides having A-DNA form and B-DNA form conformational geometry
ISIS PHARMACEUTICALS INC35 citations92
US6593466B1Jul 15, 2003
Guanidinium functionalized nucleotides and precursors thereof
ISIS PHARMACEUTICALS INC28 citations92
US6541456B1Apr 1, 2003
Antimicrobial 2-deoxystreptamine compounds
ISIS PHARMACEUTICALS INC33 citations92
US6084082AJul 4, 2000
Lactam nucleic acids
ISIS PHARMACEUTICALS INC24 citations92
US6770486B1Aug 3, 2004
Optimization of ligand affinity for RNA targets using mass spectrometry
ISIS PHARMACEUTICALS INC22 citations91
US6914148B2Jul 5, 2005
Guanidinium functionalized intermediates
ISIS PHARMACEUTICALS INC5 citations74
US5866691AFeb 2, 1999
Lactam nucleic acids
ISIS PHARMACEUTICALS INC3 citations63